Patents
Literature
Patsnap Copilot is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Patsnap Copilot

101 results about "Rate dependent" patented technology

Binning of results from loop qualification tests

The present invention provides a method and apparatus for performing line qualification tests, and binning the results of such testing. The lines are tested to determine or estimate various characteristics of the line. Physical characteristics of the line may be estimated (e.g. line length, line gauge, insertion loss). The presence of devices on the line such as load coils, bridged taps, terminations and the like may also be determined. A prediction of the data rate the loop can support is made from the measured and estimated line conditions. The results are binned according to certain criteria and to provide an easily discernable status of the line. The binning can be performed by a computer using software designed specifically for this purpose. The binned results may include a first category indicating the line cannot support a certain level of high speed access. The binned results may also include a second category indicating the line can support a certain level of high speed access. The results may also include a third category indicating the line cannot currently support a certain level of high speed access but would be able to upon removal of an impediment. A fourth category indicating the characteristics of the selected line fall outside the area of coverage of the test system may also be included. Each category may be assigned a respective color in order to make the status of the line easily discernable. The testing and binning may be performed for a variety of different high speed access levels. Customers can be charged different rates dependent upon the level of service made available to them.
Owner:TOLLGRADE COMM INC

Nonlinear inverse control method used for dynamic hysteresis compensation of piezoelectric actuator

ActiveCN106707760AAccurately describe dynamic hysteresis characteristicsHigh positioning accuracyAdaptive controlHysteresisLoop control
The invention discloses a nonlinear inverse control method used for dynamic hysteresis compensation of a piezoelectric actuator. Nonlinear inverse control of the piezoelectric actuator is performed based on a Prandtl-Ishlinskii model by aiming at the problem that most models cannot perform accurate inverse analysis for the modeling difficulty of a dynamic hysteresis system; a dynamic critical value related to the input frequency is established to obtain a rate-dependent play operator, and the rate-dependent play operator is combined with a density function so as to obtain a rate-dependent Prandtl-Ishlinskii model; a hysteresis main ring is measured under different input frequencies so as to determine model parameters; the inverse parameters of the model are inversely solved by solving an initial load curve so as to obtain a rate-dependent Prandtl-Ishlinskii inverse model; and the Prandtl-Ishlinskii model and the inverse model thereof are used for an open-loop control system so as to compensate the hysteresis nonlinear property of the piezoelectric actuator. The experiment proves that the rate-dependent Prandtl-Ishlinskii model can accurately describe the hysteresis nonlinearity of the piezoelectric actuator and the rate-dependent Prandtl-Ishlinskii inverse model enhances the positioning and control precision of a hysteresis nonlinear system.
Owner:NANJING UNIV OF SCI & TECH

Bio-compatible means for controlled drug delivery to tissue and method of use

There are provided bio-compatible means for delivery of at least one pharmaceutically active agent to a patient in need of same, comprising a bio-compatible, bio-degradable anionic or cationic carrier and at least one pharmaceutically active agent wherein the agent is cationic when the carrier is anionic and is anionic when the carrier is cationic. The delivery means further comprises at least one bio-compatible enclosing means for the carrier. This enclosing means may be bio-degradable or non bio-degradable and have a predetermined permeation gradient for the passage therethrough of the at least one pharmaceutically active agent. In an alternate embodiment the enclosing means may be biodegradable without a predetermined permeation gradient for the passage therethrough of the at least one pharmaceutically active agent. In all embodiments the active agent is ionically linked to the carrier and the carrier/active agent combination is enclosed in the enclosing means. There is also provided a method of administering at least one pharmaceutically active agent to the tissue surface of a subject in need of same at a rate dependent on the permeability and/or bio-degradability of the enclosing means of the delivery means which comprises contacting the tissue surface with a bio-compatible delivery means as described above.
Owner:ETHICON INC
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products